Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Studies show improved lipids, no blood pressure increase with MK-0859

Sep. 4, 2007

Extended release niacin/laropiprant demonstrates efficacy in dyslipidemia

Sep. 4, 2007

E-5555 inhibits thrombin-induced platelet aggregation in healthy volunteers

Sep. 4, 2007

Amgen describes new 11beta-HSD1 inhibitors with potential use in treating type 2 diabetes

Sep. 4, 2007

Modulation of mGlu5 receptor activity may provide benefit in incontinence and overactive bladder

Sep. 4, 2007

Optimization of natural Chinese medicine leads to potential treatment for alcohol addiction

Sep. 3, 2007

Novel non-nucleoside HIV reverse transcriptase inhibitors profiled at Roche

Sep. 3, 2007

Oral efficacy of new MIF inhibitor in animal models of inflammatory diseases

Sep. 3, 2007

Abbott continues to develop novel multitargeted RTK inhibitors

Sep. 3, 2007

Discovery of xanthine-based DPP-IV inhibitor BI-1356 discussed at ACS meeting

Aug. 31, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...